Author:
Frank U.,Mutter J.,Schmidt-Eisenlohr E.,Daschner F.D.
Subject
Infectious Diseases,Microbiology (medical),General Medicine
Reference20 articles.
1. Comparative in vitro activity of piperacillin combined with the beta-lactamase inhibitor tazobactam (YTR 830);Eliopoulos;Diagn Microbiol Infect Dis,1989
2. Performance standards for antimicrobial susceptibility testing; eighth informational supplement. M100-S8;National Committee for Clinical Laboratory Standards,1998
3. Piperacillin–tazobactam versus imipenem–cilastatin for treatment of intra-abdominal infections;Brismar;Antimicrob Agents Chemother,1992
4. Efficacy and safety of piperacillin/tazobactam in intra-abdominal infections;Vestweber;Eur J Surg Suppl,1994
5. Prospective randomized comparison of imipenem–cilastatin and piperacillin–tazobactam in nosocomial pneumonia or peritonitis;Jaccard;Antimicrob Agents Chemother,1998
Cited by
10 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献